Market Place
Sourcing Support
All News #Library
Intas’ Receives FDA Warning Letter
28 Apr 2026 //
FDA
Enforcement Report - Week of May 7, 2025.pdf
07 May 2025 //
FDA
Enforcement Report - Week of November 6, 2024
06 Nov 2024 //
FDA
Enforcement Report - Week of October 23, 2024
23 Oct 2024 //
FDA
Intas Pharmaceuticals is on FDA Import Alert List
10 Apr 2024 //
FDA
Intas Pharmaceuticals Limited Receives FDA Warning Letter
28 Nov 2023 //
FDA
Intas Pharmaceuticals Limited on FDA Import Alert List
14 Nov 2023 //
FDA
Intas Pharmaceuticals Receives FDA Warning Letter
01 Aug 2023 //
FDA
FDA Issues From 483 to Intas Pharmaceuticals
05 Jul 2023 //
FDA
Intas Pharmaceuticals Limited on FDA Import Alert List
06 Jun 2023 //
FDA
Intas Pharmaceuticals Limited on Health Canada Inspection List
05 Jun 2023 //
HEALTH CANADA
Enforcement Report - Week of May 31, 2023
31 May 2023 //
FDA
Enforcement Report - Week of May 10, 2023
10 May 2023 //
FDA
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
Enforcement Report - Week of January 25, 2023
25 Jan 2023 //
FDA
FDA Issues Form 483 to Intas Pharmaceuticals Ltd.
18 Jan 2023 //
FDA
FDA Issues Form 483 to Intas Pharma
12 Jan 2023 //
FDA
Intas Pharmaceuticals Limited (IPL) On Health Canada Inspection List
05 Dec 2017 //
HEALTH CANADA
US FDA Issues Form 483 to Intas Pharmaceuticals
20 Jul 2017 //
FDA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.